Fred B Craves has an estimated net worth of $3.38 Billion. This is based on reported shares across multiple companies, which include MADRIGAL PHARMACEUTICALS, INC., Twist Bioscience Corp, Dermira, Inc., INCYTE CORP, PONIARD PHARMACEUTICALS, INC., VIA Pharmaceuticals, Inc., MEDAREX INC, and EPOCH BIOSCIENCES INC.
2008 was Fred B Craves's most active year for acquiring shares with 118 total transactions. Fred B Craves's most active month to acquire stocks was the month of November. 2020 was Fred B Craves's most active year for disposing of shares, totalling 19 transactions. Fred B Craves's most active month to dispose stocks was the month of February. 2018 saw Fred B Craves paying a total of $1,947,700.68 for 96,679 shares, this is the most they've acquired in one year. In 2019 Fred B Craves cashed out on 1,203,000 shares for a total of $126,564,000.00, their largest year based on trade value.